DC
WST icon

Deere & Company’s West Pharmaceutical WST Stock Holding History

Deere & Company’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-5,906
Closed -$290K – 1057
2013
Q4 		$290K Hold
5,906
– – 0.01% 772
2013
Q3 		$243K Hold
5,906
– – 0.01% 813
2013
Q2 		$207K Buy
+5,906
New +$194K 0.01% 850

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Deere & Company's WST Position: Q1 2014 in Review

Deere & Company sold out of West Pharmaceutical (WST) in Q1 2014, closing a stake of 5,906 shares — an estimated $290K sold.

Deere & Company first reported a position in WST in Q2 2013 and held it in 3 quarters. The position peaked at $290K in Q4 2013. 226 funds tracked by Wall St. Rank hold WST as of Q1 2014.

  • Deere & Company reported no remaining West Pharmaceutical position as of Q1 2014 after selling out during the quarter.
  • Deere & Company sold 5,906 West Pharmaceutical shares in Q1 2014, an estimated $290K.
  • Deere & Company first reported a position in West Pharmaceutical in Q2 2013 and held it in 3 quarters.
  • Deere & Company's West Pharmaceutical position peaked at $290K in Q4 2013.
  • 226 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2014.

Based on Deere & Company's 13F filing for Q1 2014, filed 8 May 2014.